1[1]The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group.Tissue plasminogen activator for acute ischemic stroke.N Engl J Med,1995,333:1581-1587.
2[2]Chiu D,Krieger D,Villar-Cordova C,et al.Intravenous tissue plasminogen activator for acute ischemic stroke:feasibility,safety,and efficacy in the first year of clinical practice.Stroke,1998,29:18-22.
4[4]Tanne D,Kasner SE,Demchuk AM,et al.Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice:the Multicenter rt-PA Stroke Survey.Circulation,2002,105:1679-1685.
5[5]Demchuk AM,Morgenstern LB,Krieger DW,et al.Serum glucose level and diabetes predict tissue plasminogen activator-related intracerebral hemorrhage in acute ischemic stroke.Stroke,1999,30:34-39.
6[6]Alvarez-Sabin J,Molina CA,Montaner J,et al.Effects of admission hyperglycemia on stroke outcome in reperfused tissue plasminogen activator-treated patients.Stroke,2003,34:1235-1241.
7[7]Hacke W,Kaste M,Fieschi C,et al.Randomised doubleblind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS Ⅱ).Second European-Australasian Acute Stroke Study Investigators.Lancet,1998,352:1245-1251.
8[8]del Zoppo GJ,Higashida RT,Furlan AJ,et al.PROACT:a phase Ⅱ randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke.PROACT Investigators.Prolyse in Acute Cerebral Thromboembolism.Stroke,1998,29:4-11.
9[9]Furlan A,Higashida R,Wechsler L,et al.Intra-arterial prourokinase for acute ischemic stroke.The PROACT Ⅱ study:a randomized controlled trial.Prolyse in Acute Cerebral Thromboembolism.JAMA,1999,282:2003-2011.
10[10]Arnold M,Schroth G,Nedeltchev K,et al.Intra-arterial thrombolysis in 100 patients with acute stroke due to middle cerebral artery occlusion.Stroke,2002,33:1828-1833.
同被引文献36
1Hayakawa M. Intravenous thrombolysis for acute ischemic stroke: past, present and future. Rinsho Shinkeigaku. 2014; 54(12):1197-1199.
2Zhai YK, Zhu W J, Hou HL, et al. Efficacy of telemedicine for thrombolytic therapy in acute ischemic stroke: a meta-analysis. J Telemed Telecare. 2015.
3Hlavica M, Diepers M, Garcia-Esperon C, et al. Pharmacological recanalization therapy in acute ischemic stroke-Evolution, current state and perspectives of intravenous and intra-arterial thrombolysis. J Neuroradiol. 2015.
4Friedricn B, Gawlitza M, Schob S, et al. Distance to thrombus in acute middle cerebral artery occlusion: a predictor of outcome after intravenous thrombolysis for acute ischemic stroke. Stroke. 2015.
5Turc G, Isabel C, Calvet D. Intravenous thrombolysis for acute ischemic stroke. Diagn Interv Imaging. 2014;95(12): 1129-1133.
6Lin C, Li N, Wang K, et al, Efficacy and safety of endovascular treatment versus intravenous thrombolysis for acute ischemic stroke: a meta-analysis of randomized controlled trials. PLoS One. 2013;8(10):e77849.
7Singh B, Parsaik AK, Prokop L J, et al. Endovascular therapy for acute ischemic stroke: a systematic review and meta-analysis. Mayo Clin Proc. 2013;88(10):1056-1065.
8Bae GS, Kwon H J, Kang CW, et al. Mechanical thrombectomy using a solitaire stent in acute ischemic stroke; initial experience in 40 patients. J Cerebrovasc Endovasc Neurosurg. 2012;14(3):164-169.
9Serrene JC, Jimenez L, Ringer AJ. The role of endovascular therapy inthe treatment of acute ischemic stroke. Neurosurgery. 2014;74 Suppl 1:S133-S141.
10Turk AR, Campbell JM, Spiotta A, et al. An investigation of the cost and benefit of mechanical thrombectomy for endovascular treatment of acute ischemic stroke. J Neurointerv Surg. 2014;6(1 ):77-80.
